Ongoing studies suggest MKK3 plays an oncogenic role; identified among the upregulated target genes by p53 gain-of-function mutants, its specific knockdown significantly affects proliferation and survival in cancer lines of different tumor types (breast, colon, melanoma), both in vitro and in vivo by inducing autophagy and cell death. Here, MAP2K3 is linked to neoplasm.